Geoffrey von Maltzahn

Fondateur chez Resonance Therapeutics

Profil

Dr. Geoffrey von Maltzahn is a Chairman at Quotient Therapeutics Ltd., a Chairman at Tessera Therapeutics, Inc., a Chief Innovation Officer & Director at Indigo Ag, Inc., a General Partner at Flagship Pioneering, Inc. and a Founder at Resonance Therapeutics.
He is on the Board of Directors at Expedition Medicines, Inc., Mirai Bio, Tessera Therapeutics, Inc. and Indigo Ag, Inc. Dr. von Maltzahn was previously employed as an Independent Director by Sana Biotechnology, Inc., a Founder by Seres Therapeutics, Inc., a Vice President-Discovery by Pronutria Biosciences, Inc., a President, Chief Executive Officer & Director by Cobalt Biomedicine, Inc., a Vice President-Corporate Development by Essentient, Inc., and a Founder by Sienna Biopharmaceuticals, Inc. He also served on the board at Generate Biomedicines, Inc. and Kaleido Biosciences, Inc. He received his undergraduate degree from Massachusetts Institute of Technology, a graduate degree from the University of California San Diego and a doctorate degree from Massachusetts Institute of Technology.

Postes actifs de Geoffrey von Maltzahn

Sociétés	Poste	Début
Resonance Therapeutics	Fondateur	17/09/2009
Indigo Ag, Inc.	Fondateur	01/01/2013
Flagship Pioneering, Inc.	Private Equity Investor	01/01/2009
Tessera Therapeutics, Inc.	Fondateur	01/01/2018

Anciens postes connus de Geoffrey von Maltzahn

Sociétés	Poste	Fin
KALEIDO BIOSCIENCES, INC.	Fondateur	15/03/2022
SANA BIOTECHNOLOGY, INC.	Directeur/Membre du Conseil	01/09/2021
Cobalt Biomedicine, Inc.	Directeur Général	01/02/2019
Essentient, Inc.	Corporate Officer/Principal	17/02/2014
AXCA HEALPAR	Fondateur	01/01/2013